Exploration into conolidine has resulted in discovery of an opioid receptor in the human body identified as ACKR3/CXCR7. ACKR3 seems to be by far the most desired target for conolidine, which also disregards the opposite 4 classical opioid receptors(3). Presented the mechanism of motion of conolidine not like opioids https://sethuuolk.blue-blogs.com/45535485/how-much-you-need-to-expect-you-ll-pay-for-a-good-conolidin-to-replace-traditional-painkillers